Paper3690980
Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism.
Clements MR and 5 others. Clin Sci (Lond), 1987. Cited by 124 papers, by iCite.
Cite this record
ConductScience Library. Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism. Papers, record 3690980. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3690980
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcifediol | Major topic |
| Hyperparathyroidism | Major topic |
| Aged | |
| Feces | |
| Female | |
| Half-Life | |
| Humans | |
| Male | |
| Middle Aged | |
| Parathyroid Glands |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 124 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42588127 | Vitamin D Supplementation in Primary Hyperparathyroidism: Analysis of Benefits and Hazards. | Nutrients | 2026 | https://conductscience.org/library/papers/42588127 | PubMed |
| 41978112 | Differential and Dose-Dependent Redistribution of Vitamin D Metabolites After Acute High-Intensity Exercise in Mixed Martial Arts Athletes and Untrained Men: Pilot Study. | Nutrients | 2026 | https://conductscience.org/library/papers/41978112 | PubMed |
| 40718751 | Micro-costing analysis from Italian Guidelines for the management of sporadic primary hyperparathyroidism. | Glob Reg Health Technol Assess | 2025 | https://conductscience.org/library/papers/40718751 | PubMed |
| 38772934 | Risk of Malignant Neoplasm in Patients with Primary Hyperparathyroidism: A Systematic Review and Meta-analysis. | Calcif Tissue Int | 2024 | https://conductscience.org/library/papers/38772934 | PubMed |
| 38644730 | Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism. | Endocr Metab Immune Disord Drug Targets | 2024 | https://conductscience.org/library/papers/38644730 | PubMed |
| 38115826 | Vitamin D Deficiency and the Presentation of Primary Hyperparathyroidism: A Mini Review. | Int J Endocrinol | 2023 | https://conductscience.org/library/papers/38115826 | PubMed |
| 37694586 | Influence of Vitamin D Deficiency on Cyclin D1-Induced Parathyroid Tumorigenesis. | Endocrinology | 2023 | https://conductscience.org/library/papers/37694586 | PubMed |
| 37324304 | Differences in the Clinical Presentation and Biochemical Profile of the Patients with Primary Hyperparathyroidism with regard to their Serum Vitamin D Levels: a Single-center Experience. | Indian J Surg Oncol | 2023 | https://conductscience.org/library/papers/37324304 | PubMed |
| 35919112 | Analysis of the cause and management of persistent laboratory abnormalities occurring after the surgical treatment of primary hyperparathyroidism. | Ann Surg Treat Res | 2022 | https://conductscience.org/library/papers/35919112 | PubMed |
| 35803612 | Hungry bone syndrome like presentation following single-dose denosumab for hypercalcaemia secondary to sarcoidosis with IgA nephropathy. | BMJ Case Rep | 2022 | https://conductscience.org/library/papers/35803612 | PubMed |
| 34950830 | Vitamin D and Skeletal Muscle: Current Concepts From Preclinical Studies. | JBMR Plus | 2021 | https://conductscience.org/library/papers/34950830 | PubMed |
| 34940947 | Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? | Rev Endocr Metab Disord | 2021 | https://conductscience.org/library/papers/34940947 | PubMed |
| 33918966 | Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management. | J Clin Med | 2021 | https://conductscience.org/library/papers/33918966 | PubMed |
| 33659951 | Is it reasonable to ignore vitamin D status for musculoskeletal health? | Fac Rev | 2020 | https://conductscience.org/library/papers/33659951 | PubMed |
| 33114526 | Skeletal Muscle and the Maintenance of Vitamin D Status. | Nutrients | 2020 | https://conductscience.org/library/papers/33114526 | PubMed |
| 31967036 | A DRAMATIC RESPONSE TO DENOSUMAB: PROTRACTED HYPOCALCEMIA RELATED TO HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1-ASSOCIATED ADULT T-CELL LEUKEMIA/LYMPHOMA. | AACE Clin Case Rep | 2019 | https://conductscience.org/library/papers/31967036 | PubMed |
| 31598576 | The Role of Skeletal Muscle in Maintaining Vitamin D Status in Winter. | Curr Dev Nutr | 2019 | https://conductscience.org/library/papers/31598576 | PubMed |
| 29404903 | Pre-operative localization of abnormal parathyroid tissue by 99mTc-sestamibi in primary hyperparathyroidism using four-quadrant site analysis: an evaluation of the predictive value of vitamin D deficiency. | Endocrine | 2018 | https://conductscience.org/library/papers/29404903 | PubMed |
| 28885621 | Primary hyperparathyroidism. | Nat Rev Endocrinol | 2018 | https://conductscience.org/library/papers/28885621 | PubMed |
| 28452288 | 25(OH)D levels in trained versus sedentary university students at 64° north. | Int J Circumpolar Health | 2017 | https://conductscience.org/library/papers/28452288 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3690980
GET https://conductscience.org/api/papers/v1/3690980/cited_by?page=2